Drawing for WIM JECT

USPTO serial 79364811

WIM JECT

Reviewed by CopyMark Law Group

Reg. 7561392Status 700Registered
Filing date
Status date
Registration date
Nov 12, 2024
Examiner
FRENCH, CURTIS W
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with WIM JECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

F. William McLaughlin

F. William McLaughlin Wood Phillips500 W MadisonSuite 1130Chicago, IL 60661

Goods and services

ClassDescriptionStatusFirst use
005pre-filled syringes for medical purposes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Pre-filled syringes for medical purposes sold filled with pharmaceutical for the treatment of viral diseases, pharmaceutical for infusions, pharmaceutical for injections, diluents, emergency pharmaceuticals, active pharmaceutical ingredients; syringes sold filled with pharmaceuticals for skin care, skin regeneration, skin moisturization, aesthetic treatments, hyaluronic acids, Botulinum toxin and pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, wrinkles, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; syringes sold filled with pharmaceutical for the treatment of viral diseases, pharmaceutical for infusions, pharmaceutical for injections, diluents, emergency pharmaceuticals, active pharmaceutical ingredientsACTIVE—
010Dental syringes; syringes for medical purposes; medical syringe needles; Medical syringes for injections; medical syringes in the form of pens; Medical insulin syringes in the nature of insulin pens sold empty; disposable nozzles for dental syringes; disposable needles for medical hypodermic syringes; syringes for dental purposes; nozzles for dental syringes; injection syringes for cosmetic surgery; disposable medical syringes for aesthetic treatments; medical venom extraction syringes; hypodermic syringes for use in administering injection substances; medical spinal syringes; medical fluid injectors for medical purposes; hypodermic needles; hypodermic injection apparatus; injection instruments without needles; injection device for pharmaceuticals; injection needles for medical use; injection sleeves for medical use; hypodermic syringes for injections for medical purposes; disposable syringes; disposable hypodermic syringes for surgical use; disposable hypodermic syringes for medical use; cannulae; tubing for use with cannulas; surgical apparatus and instruments; surgical apparatus and instruments for dental use; surgical apparatus and instruments for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 30, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 12, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 3, 2025FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Apr 11, 2025FICSFINAL DISPOSITION NOTICE SENT TO IB—
Apr 11, 2025FIMPFINAL DISPOSITION PROCESSED—
Feb 12, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 12, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 12, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 27, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 27, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 24, 2024OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Aug 7, 2024OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 7, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 7, 2024OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jul 24, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 1, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 1, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 1, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2024RFNTREFUSAL PROCESSED BY IB—
Apr 30, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 30, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 2024ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Apr 23, 2024PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Apr 11, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 22, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 22, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 22, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 17, 2023RFNTREFUSAL PROCESSED BY IB—
Sep 25, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 25, 2023RFRRREFUSAL PROCESSED BY MPU—
Sep 6, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 5, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 30, 2023DOCKASSIGNED TO EXAMINER—
Mar 21, 2023MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 17, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 9, 2023REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance